Dr. Skibola recently joined the faculty at UAB as a Professor of Epidemiology. She received her BS in Nutritional Sciences from the UC Berkeley College of Natural Resources, and her MS and PhD degrees from the UC Berkeley School of Public Health where she remained as faculty in the Division of Environmental Health Sciences. She has over 12 years of experience in teaching and research in the area of environmental health science and molecular epidemiology. Dr. Skibola has served as Chair of the InterLymph Consortium (International Consortium of Investigators Working on Non-Hodgkin Lymphoma Epidemiologic Studies) from 2007-2011, and as co-Chair of the InterLymph Genetics Working Group since its inception in 2002. From 2005-2012, she has also served as co-Leader of the Toxicogenomics Core Facility, Superfund Research Program at UC Berkeley.
Dr. Skibola has expertise and a broad background in molecular epidemiology, toxicology and genomics, aimed at identifying genetic and environmental risk factors of chronic disease with an emphasis in lymphoma, and to determine the mechanisms involved. Her recent work has led to the discovery of genetic variants underlying follicular lymphoma through large population studies. This work has culminated in the publication of multiple high-impact manuscripts in leading scientific journals and has highlighted the relevance of common disease-associated variants in the human leukocyte antigen (HLA) region in lymphoma risk. More broadly, this work has had important implications for the community of disease geneticists as Dr. Skibola has integrated and developed new strategies for conducting functional follow-up studies of disease-associated gene variants. In addition to this work, Dr. Skibola is a collaborator on several projects examining emerging technologies to develop biomarkers for human studies.